검색어: invega (핀란드어 - 영어)

INVEGA
INVEGA

Invega paliperidoni
Invega paliperidone

INVEGA 9 mg
INVEGA 9 mg

Mitä Invega on?
What is Invega?

Koska INVEGA -
For patients with moderate to severe renal impairment (creatinine clearance ≥ 10 to < 50 ml/ min), the recommended initial dose of INVEGA is 1.5 mg every day, which may be increased to 3 mg once daily after clinical reassessment.

Mitä INVEGA on?
What is INVEGA?

Mitä INVEGA sisältää
What INVEGA contains

invega 1,5 mg
invega 1.5 mg

INVEGA 6 mg depottabletti
INVEGA 6 mg prolonged-release tablets

Muut lääkevalmisteet ja INVEGA
Other medicines and INVEGA

INVEGA alkoholin kanssa
INVEGA with alcohol

INVEGA-depottablettien säilyttäminen
How to store INVEGA

Miten Invega vaikuttaa?
How does Invega work?

Älä ota INVEGA- depottabletteja
Do not take INVEGA

Annettaessa INVEGA- valmistetta
Potential for other medicines to affect INVEGA In vitro studies indicate that CYP2D6 and CYP3A4 may be minimally involved in paliperidone metabolism, but there are no indications in vitro nor in vivo that these isozymes play a significant role in the metabolism of paliperidone.

INVEGA- DEPOTTABLETTIEN SÄILYTTÄMINEN
HOW TO STORE INVEGA

INVEGA otetaan suun kautta.
INVEGA is for oral administration.

Miksi Invega on hyväksytty?
Why has Invega been approved?

Miksi INVEGA on hyväksytty?
Why has INVEGA been approved?

INVEGA-depottabletit ovat kapselinmuotoisia.
INVEGA prolonged-release tablets are capsule shaped.